A Study to Evaluate the Safety and Efficacy of THR-317 for the Treatment of Diabetic Macular Oedema (DME)

Clinical trial NCT03071068 · COMPLETED

Trial details

NCT number: NCT03071068
Sponsor: ThromboGenics
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Diabetic Retinopathy Macular Edema

Start date: 2016-12-22
Primary completion: 2018-04-01
Enrollment: 49

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.